People on the Move – August 6, 2019

0
102

By Matt Skoufalos

 

David I. Sternberg

The Barbara Ann Karmanos Cancer Institute of Detroit, Michigan added thoracic surgeon David I. Sternberg. Sternberg also will serve on the Karmanos tumor board. He is a member of the American Medical Association, American Board of Surgery, Society of Thoracic Surgery, and the American Board of Thoracic Surgeons.

 

FAIR Health of New York, New York will add Martin Makary as a policy advisor. Makary is a professor of health policy and management at the Johns Hopkins Bloomberg School of Public Health and a professor of surgery at the Johns Hopkins University School of Medicine. He is Chief of the Johns Hopkins Islet Transplant Center, founder of the Johns Hopkins Center for Surgical Outcomes Research and Clinical Trials, and Executive Director of Improving Wisely, a national collaborative to reduce unnecessary care.

 

The Tampa, Florida-based Savii, Inc. named Keri Lamont its VP of growth and optimization. Lamont previously worked as director of area sales for Bayada Home Health Care.

 

Lannett Company, Inc. of Philadelphia, Pennsylvania named John Kozlowski its CFO, succeeding the retiring Martin Galvan, who will continue with the company in an advisory capacity. Kozlowski presently serves as Lannett chief of staff and strategy officer. Prior to joining Lannett, he held senior finance positions with Finisar Australia (formerly Optium Australia) and Optium Corporation. Kozlowski holds a Rider University MBA. and a Bachelor’s degree in finance from James Madison University.

 

Peter Nakaji, MD

Banner Health of Phoenix, Arizona has appointed Peter Nakaji as Physician Executive of Neurosurgery at Banner Health, Physician Executive Director of the Banner – University Medicine Neuroscience Institute, and Chair of the Department of Neurosurgery at Banner for the University of Arizona College of Medicine – Phoenix. Nakaji joins Banner from Barrow Brain and Spine, where he has practiced for 15 years. He has also served for nearly a decade as the Director of the Neurosurgery Residency Program at Barrow Neurological Institute.

 

Dr. Kristine Lokken (L) Dr. Mary Kay Ross (R) Opening the Brain Health and Research Institute in Seattle, WA on September 1, 2019

The Seattle, Washington-based Brain Health and Research Institute (BHRI) has added neuropsychologist Kristine Lokken. Lokken has worked in academic behavioral medicine and neuropsychology for 25 years, and co-founded a precision brain health clinic in Birmingham.

 

Emmanuel d’Harcourt

Helen Keller International of New York, New York named Emmanuel d’Harcourt its new Chief Program and Innovation Officer. d’Harcourt succeeds Victoria Quinn, who retired in January 2019 after more than 12 years in the position. d’Harcourt has been Senior Health Director of the International Rescue Committee (IRC), and most recently was a consultant for Vital Health Strategies.

 

The Dallas, Texas-based CCRM (Colorado Center for Reproductive Medicine) added fertility specialist Yetunde Ibrahim. Ibrahim is board certified in obstetrics and gynecology, and joins CCRM from Salt Lake City, Utah.

 

Bridge Bank of Boston, Massachusetts added Alex Augustyn as its VP, relationship manager.

 

Select Medical Holdings Corporation of Mechanicsburg, Pennsylvania named Daniel Thomas to its board of directors and the Select Medical Audit Committee. Thomas’ term will expire at the Select Medical 2020 annual meeting, at which time he will stand for election along with the other director nominees. Thomas has 30 years of healthcare industry experience, and is an active board member for: Concentra Group Holdings Parent, LLC (a joint venture subsidiary of Select Medical), Healthcare Highways, Inc., and National Partners in Healthcare. From 2011 to 2017, Thomas was president, CEO and a board member of Provista, Inc.; he was also president and a board member at Viant, Inc., and spent 14 years with Concentra, Inc., where he was president, CEO, and COO.

 

The Baltimore-based University of Maryland School of Medicine (UMSOM) named Christine Lau, Chief of the Division of Thoracic Surgery at the University of Virginia (UVA), Chair of the Department of Surgery at UMSOM and Chief of Surgery at the University of Maryland Medical Center (UMMC), effective full-time on December 1, 2019. Prior to joining the University of Virginia, Lau was an Assistant Professor of Surgery at the University of Michigan School of Medicine in Ann Arbor, MI.

 

Debbie Landers

Briye of Nashville, Tennessee promoted president and COO Debbie Landers to CEO, making her the first woman to hold the position in the history of the company.

Landers has been an executive consultant, national speaker, and author; she most recently led development of new business line opportunities and Patient Experience strategy atStuder Group and Jarrard, Phillips, Cate & Hancock. Landers has an MBA from Bellarmine University.

 

Telligen of West Des Moines, Iowa named Denise Levis Hewson to its board of directors. Levis Hewson is EVP of care management and provider services for Community Care of North Carolina and COO of the Community Care Physician Network.

 

The Denver, Colorado-based DaVita Health Solutions named Dorothy Fisher its national medical director and Ian Laird its national VP of growth. Prior to this role, Fisher led strategic partner relations as a medical director at Geisinger Health Plan.

Laird was the staff VP of business development at CareMore Health.

 

Castlight Health, Inc. of San Francisco, California promoted EVP of product and customer experience Maeve O’Meara to CEO and a member of its board of directors; CFO Siobhan Nolan Mangini will retain her position while also becoming president of the company. Director and CEO John Doyle is resigning immediately. O’Meara joined the company in 2010, and was previously its Chief Product Officer and SVP of Products.

 

Circuit Clinical of Buffalo, New York added Craig Lipset to the Empirican Group Inc. Board of Directors. Lipset was recently Head of Clinical Innovation within Global Product Development at Pfizer.

 

The Philadelphia, Pennsylvania-based Health Union added Will Rompala as Chief Technology Officer (CTO). Rompala was recently head of technology for North America at Kantar Media and CTO at Sidecar.

 

Brent James, MD, MStat

Amplifire of Boulder, Colorado name Brent James chairman of its healthcare alliance clinical innovation advisory board. James is a Senior Fellow at the Institute for Healthcare Improvement (IHI), a senior advisor at both the Leavitt Group and at Health Catalyst, and holds at various universities. He was formerly VP and Chief Quality Officer at Intermountain Healthcare.

 

Paul Castaldo

The Philadelphia, Pennsylvania-based Tridiuum named Paul Castaldo its SVP of Corporate Development. Castaldo spent 30 years at Kaiser Permanente, most recently as Regional Behavioral Health Care Leader with the Southern California Permanente Medical Group.

 

Joseph R. Ficalora

The Patient Innovations Advisory Board of New York, New York added New York Community Bancorp president and CEO Joseph R. Ficalora. New York Community Bancorp is the 25th largest bank holding company in the nation.

 

Prat Vemana

Kaiser Permanente of Oakland, California named Mike Ramseier regional president for Kaiser Permanente in Colorado and Prat Vemana its first chief digital officer for Kaiser Foundation Health Plan and Hospitals. Ramseier was president of Anthem Blue Cross and Blue Shield in Colorado from 2011 to 2017, and most recently was EVP and market president for the Western region of Beacon Health Options. Vemana is currently chief product and experience officer at The Home Depot; he will join Kaiser Permanente August 12.

 

The New York, New York-based Renalytix AI plc named Thomas McLain its President and Chief Commercial Officer. McLain joins the company from Exosome Diagnostics, where he was most recently GM, President and CEO, and COO. McLain has been President and CEO of Vermillion, CEO of start-up Claro Scientific, and Chairman, CEO and President of Nabi Biopharmaceuticals.

 

Pfizer division Upjohn will merge with Mylan, creating the world’s largest generic drug-maker. The new company, which will be renamed and rebranded at the close of the sale, will be led by current Mylan Chairman Robert J. Coury as Executive Chairman; current Upjohn Group President Michael Goettler as CEO; and current Mylan President Rajiv Malik as President. Current Mylan CFO Ken Parks is leaving, and current Mylan CEO Heather Bresch will retire. Eight members of its board of directors will be designated by Mylan, and three members will be designated by Pfizer, for a total of thirteen. The new company will be incorporated in Delaware, and will operate Global Centers in Pittsburgh, Pennsylvania; Shanghai, China, and Hyderabad, India.

LEAVE A REPLY

Please enter your comment!
Please enter your name here